KDC-MN-145 – Kodiac biolabs

Plain-language summaryIntrigue 55 / 100

L-tyrosine is the amino acid precursor for catecholamine neurotransmitters (dopamine, norepinephrine, epinephrine). Supplementation may help during stress, sleep deprivation, or cold exposure when catecholamines deplete faster than they are synthesized. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Our opinion on this compoundBasic amino acid

25/100

Well-understood catecholamine precursor with context-dependent stress signal and minimal research frontier value

Look, L-Tyrosine is exactly what it says it is: a dietary amino acid that sits at the top of the catecholamine biosynthesis ladder. Tyrosine hydroxylase converts it to L-DOPA, and from there you get dopamine, norepinephrine, epinephrine. That pathway has been understood since the 1960s. Theres nothing mechanistically new here, and we dont think theres much point pretending otherwise.

The stress-depletion framing is the only angle that generates any genuine research interest. The core hypothesis is that under conditions of high catecholamine demand, specifically sleep deprivation, cold exposure, sustained vigilance tasks, tyrosine hydroxylase may become substrate-limited. If so, supplementation could in principle restore catecholamine synthesis capacity faster than dietary intake alone would. That logic is physiologically sound. The problem is that the effect in practice is modest, highly context-dependent, and most prominent in subjects who are already meaningfully stressed or depleted. In rested, replete humans, the signal essentially disappears. That’s a real finding, but it’s not a surprising one and it’s not a frontier one.

On the human evidence side, we actually have multiple well-run studies here, with the Deijen group and others replicating cognitive task performance effects under acute stress. N-back performance, tracking task accuracy, subjective alertness under sleep loss, these endpoints show measurable but small effect sizes when tyrosine is given acutely before or during a stressor. Thats a cleaner dataset than many compounds in our library. The issue isnt evidence quality. Its that the question these studies answer is not a question that serious bench investigators are actively racing to resolve in 2026.

Differentiation is poor. NALT (N-acetyl-L-tyrosine) is frequently preferred by formulators for claimed bioavailability reasons, though the evidence there is also murky. Mucuna pruriens delivers L-DOPA directly and bypasses the tyrosine hydroxylase rate-limit entirely if you actually want to push catecholamine tone. If someone is studying catecholamine biology at the bench, they have better tools than oral tyrosine. The compound has almost no probe value for a research program that isn’t specifically studying precursor loading dynamics.

Honestly, the compound belongs in a formulators pantry, not on a frontier research shortlist. What we like: the evidence is real, the mechanism is clean, the sourcing is trivial. What we dont like: none of those things make it interesting as a research target in 2026. The novelty axis in particular is terminal here. This is a 60-year-old molecule with a settled mechanism and a modest, well-characterized effect. If your program is specifically about catecholamine depletion models in human subjects, tyrosine has a role. Otherwise, its background noise.

Novelty: 12
Mechanism promise: 20
In-category differentiation: 15
Evidence quality: 48
Translational signal: 42
Research bench value: 25

Rationale L-Tyrosine is a foundational amino acid with textbook-level mechanism; raw scores land well below the basic-aa cap of 32. Evidence quality and translational signal are real but modest and context-specific, not enough to lift overall above 25.

Catecholamine precursor amino acid

An aromatic amino acid precursor of L-DOPA, dopamine, norepinephrine, and epinephrine; supplemented for stress-related catecholamine support.

Abstract

L-Tyrosine (CAS 60-18-4; molecular formula C9H11NO3; molecular weight 181.19) is an aromatic amino acid precursor in the catecholamine biosynthesis pathway: tyrosine → L-DOPA (via tyrosine hydroxylase) → dopamine → norepinephrine → epinephrine. Supplementation has been studied for cognitive performance under stress conditions where catecholamine demand is high (sleep deprivation, cold exposure, sustained vigilance tasks); modest improvements in cognitive endpoint measures have been reported. Effects on resting cognitive performance are minimal. Tyrosine hydroxylase is the rate-limiting enzyme; supplementation can increase substrate availability when the enzyme is operating below saturation. Doses are typically 500 mg to 2 grams per day.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, sourcing and quality verification, and a curated reference list. Embedded inline below; download for offline reading.

KDC-MN-145Open in new tab →

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Tag: KDC-MN-145

L-Tyrosine

Abstract

Read the full monograph